A recently released CompPharma survey of 25 major workers’ comp insurers found that generic drugs are becoming a potent weapon against rising prescription drug costs in the industry, especially over the concern about opioids. The national pharmacy benefit manager, headed by President and Managed Care Matters blogger Joe Paduda, found that 81.2% of all surveyed prescriptions for comp claims in 2013 were filled with generics; that constitutes an increase from 75.7% last year. Paduda welcomes state laws that require physicians to prescribe generics whenever possible and cite the correlation between cost reduction using generics and overall cost reduction in year over year data.
Read an overview of the survey from WorkCompCentral (paid content) here.
Access the survey report from CompPharma here.